Bovine Colostrum
Also sold as: Bovine colostrum · Colostrum bovinum · First milk
A dairy-derived mixture of proteins and bioactive constituents, commonly marketed for gut and immune health. Human effects differ by illness, formulation and exercise context; routine wellness claims exceed the evidence.
Energy
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Energy: Recovery and biomarker signals exist, but sport RCTs do not consistently improve actual performance; everyday energy benefit is unestablished.
REALITY CHECK // Colostrum is not a universal leaky-gut cure: an acute n=8 exercise trial suggested protection, while an n=30 eight-week running trial found increased permeability. Respiratory symptom signals do not equal a demonstrated broad immune boost, and pediatric diarrhea findings cannot be transferred directly to healthy adults.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
01 // STUDIED_DOSE_RANGE
10–60 g/day across heterogeneous studies
This is whole colostrum product mass, not IgG mass; trial formulation and population matter.
02 // TIMING_&_MATRIX
Check IgG and dairy content
Typical source marker values are approximately 15–40%. Freeze-dried, spray-dried and capsule labels are not clinical equivalence claims.
03 // EVALUATION_WINDOW
Acute versus 4–12 weeks
Small barrier studies assessed acute exercise responses; longer immune/sport studies often ran 4–12 weeks. Results conflict across settings.
04 // SAFETY_&_QUALITY_GATE
Milk allergy and quality gate
Milk-protein allergy is distinct from lactose intolerance. No UL is established and high-dose long-term safety is unresolved; verify batch testing.
UPPER LIMIT // No EFSA/NIH upper intake level is established for bovine colostrum. Studied 10–60 g/day exposures are not a safety ceiling; high-dose long-term data are insufficient.
Summary
Some small RCTs report fewer respiratory symptoms, but pooled immune markers show little or no effect and the mechanism is unresolved. Acute exercise-related gut-permeability findings conflict with an eight-week high-dose running study that increased permeability. The clearest pooled clinical signal concerns sick children with infectious diarrhea, not healthy adults seeking wellness.
Mechanism
Immunoglobulins, lactoferrin and other constituents may act locally within the gut. Barrier and immune hypotheses do not establish systemic absorption or prove that a higher IgG label yields stronger clinical benefit.
Typical studied dose
The dossier reports heterogeneous exposures of 10–60 g colostrum/day, usually over 4–12 weeks. One running RCT used 60 g/day for eight weeks; acute barrier work assessed responses after 2 and 14 days. IgG commonly varies around 15–40% by product. Trial mass is whole product, not isolated IgG and not a general dosing prescription.
Upper limit
No EFSA/NIH upper intake level is established for bovine colostrum. Studied 10–60 g/day exposures are not a safety ceiling; high-dose long-term data are insufficient.
Popular stacks with Bovine Colostrum
Not enough stack data yet. A combination with Bovine Colostrum appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Freeze-dried colostrum, illustrative 40% IgG specification Best for: Comparing whole-product mass while showing a declared IgG marker. |
Extract weight · ~40% marker | 10000–60000 mg | Lower-temperature processing may preserve bioactive proteins, but superior clinical outcomes are not established. Loose stools/bloating can occur; milk allergy is a separate risk. |
Studied standard [SOURCE // FORM_SPECIFIC] 40% is the supplied example marker specification, not a universal freeze-dried content. Compare whole-product mass with the heterogeneous 10–60 g trial interval; do not multiply twice. |
| Spray-dried colostrum (IgG not specified) Best for: Recognizing a common commercial preparation requiring its own assay. |
Unstandardized: active content unknown | no comparable trial range | Heat may affect some protein activity; clinical superiority of processing claims is unproved. Usually tolerated; dairy and dose-related GI issues remain. |
Caution [SOURCE // CHECK_LABEL] The source gives no actual IgG percentage or processing-specific trial interval; 100% active is not assumed. |
| Colostrum capsules/tablets (IgG not specified) Best for: Checking portion size and total daily product mass. |
Unstandardized: active content unknown | no comparable trial range | Convenience does not establish equal exposure to high-mass powder studies. Usually tolerated, with the same dairy risks. |
Caution [SOURCE // CHECK_LABEL] A small capsule serving may be far below many trial exposures. No capsule-specific IgG fraction or trial interval is extracted. |
| Colostrum with illustrative 15% IgG specification Best for: Contrasting two source-supported ends of the 15–40% IgG specification range. |
Extract weight · ~15% marker | 10000–60000 mg | An IgG marker supports product comparison; clinical response cannot be inferred from that marker alone. GI tolerance depends on total product and individual dairy tolerance. |
Caution [SOURCE // CHECK_LABEL] 15% is an illustrative label specification within the source range, not a verified commercial product. Whole-product trial mass remains the comparison basis. |
Common label traps
- TRAP_01 // COLOSTRUM SEALS EVERY LEAKY GUT
Acute exercise protection and chronic high-dose permeability increases both occur in the dossier; neither establishes a cure for IBS, reflux or a broadly defined leaky gut. - TRAP_02 // IMMUNE BOOST MEANS YOU WILL NOT GET SICK
Some small trials report fewer respiratory symptoms, but pooled serum/salivary immune markers show little or no benefit; prevention is not guaranteed. - TRAP_03 // SIDE EFFECTS PROVE DETOX OR PREMIUM SOURCING PROVES EFFICACY
Loose stools, anxiety or brain fog are not proof of a cleansing effect. Raw/grass-fed claims and higher price do not establish better clinical outcomes.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- RESPIRATORY SYMPTOMS Limited · benefit
Some small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
PMID 32276466 PMID 37111143 PMID 24200515 PMID 12923655 PMID 37630816 PMID 34073917 - SALIVARY IgA Limited · benefit
Individual runner/swimmer RCTs reported changes, but pooled analysis did not find a significant salivary-IgA effect. This surrogate does not establish causally fewer infections.
PMID 16676703 PMID 20601740 PMID 32276466 - ACUTE EXERCISE PERMEABILITY Limited · benefit
An n=8 crossover RCT found an approximately threefold exercise-related lactulose:rhamnose rise (0.32 to 1.0; p<.01). Colostrum or zinc-carnosine attenuated the rise by about 70% after 14 days; the combination showed about 30% attenuation after two days. Related heat/exercise marker trials support a narrow acute context.
PMID 27357095 PMID 28290057 PMID 29574607 - CHRONIC PERMEABILITY CONFLICT Limited · makes it worse
In n=30 adult male runners receiving 60 g/day for eight weeks, L/R rose 251 +/- 140% with colostrum versus 21 +/- 35% with whey (p<.05) and -7 +/- 13% in controls (p<.02). This potentially adverse chronic result must be shown alongside acute protection; increased macromolecular transport is one hypothesis.
PMID 22253980 - NSAID-RELATED PERMEABILITY Limited · benefit
One small human trial found reduced acute indomethacin-related permeability with colostrum; it does not establish long-term protection from NSAID injury.
PMID 11352778 - PEDIATRIC INFECTIOUS DIARRHEA Strong · benefit
A five-RCT meta-analysis in sick children found 1.42 fewer stools/day (95% CI -2.70 to -0.14), diarrhea occurrence OR 0.29 (95% CI 0.16–0.52), and pathogen detection OR 0.29 (95% CI 0.08–0.71). OR 0.29 means lower odds, not an established 71% absolute or relative risk reduction; findings do not establish healthy-adult prophylaxis.
PMID 30816291 PMID 38409162 - SPORT PERFORMANCE Limited · no benefit
Endurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
PMID 12188088 PMID 12432178 PMID 28285432 PMID 15789141 PMID 38004173 PMID 39497827 - BODY FAT AND LIPIDS No established evidence
A 2026 systematic review is indexed, but the source explicitly leaves direction unresolved. No weight-loss or lipid-treatment claim can be inferred from that citation.
PMID 42197039
Reader questions
Does colostrum treat IBS, reflux or leaky gut?
The dossier does not establish that claim. Small acute exercise findings conflict with a chronic high-dose running trial; diagnosed gut disease needs clinical assessment.
Is freeze-dried or grass-fed automatically more effective?
No comparative clinical superiority is established. Examine IgG specification, dairy content, processing and independent testing rather than price or sourcing slogans.
Are loose stools or unusual symptoms detox?
No. Treat them as possible adverse effects. Milk-protein allergy is a contraindication, and low-lactose labeling does not remove allergy risk.
Does it raise IGF-1, estrogen or body weight?
The source reports no circulating IGF-1 rise in healthy-adult studies, but the corresponding catalog entry lacks a title/year and needs verification. Estrogen/weight-gain claims are not established; sport-rule status requires current checks.
Stack interactions
- Caution Immunosuppressants and autoimmune conditions [CAUTION // EVIDENCE_CONTEXT]
Caution is theoretical because colostrum contains immunoactive proteins; a clinically established drug interaction is not demonstrated. - Caution Zinc-carnosine [CAUTION // EVIDENCE_CONTEXT]
In an n=8 crossover exercise study, combined treatment attenuated the acute permeability response earlier than either alone. This is a narrow exercise finding, not proof of treating chronic gut disease.
PMID 27357095 - Caution Antibiotics [CAUTION // EVIDENCE_CONTEXT]
The source documents no negative pharmacokinetic interaction. Clinical adjunct use in diarrhea is not a reason to change prescribed antibiotic care.
Red flags: interactions and who should avoid it
Interactions
Immunosuppressants/autoimmune conditions: theoretical caution from immunoactive constituents, not a confirmed clinical interaction. A very small exercise RCT tested zinc-carnosine coadministration; it does not establish general synergy for gut disease. No negative antibiotic interaction is documented in the supplied source.
Avoid or ask a doctor first if
Cow-milk protein allergy is a contraindication; low-lactose products do not remove milk-protein allergy risk. Lactose intolerance may cause GI symptoms. Pregnancy/breastfeeding and immunosuppression require individualized review. Stop/review loose stools, bloating or other adverse symptoms rather than calling them detox. Competitive athletes should check current sport-specific guidance and product testing; historical growth-factor concerns are not proof of a doping violation.
Sources (PubMed, 22)
- Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
PMID 11352778 · 2001 · randomized controlled trialOne small human trial found reduced acute indomethacin-related permeability with colostrum; it does not establish long-term protection from NSAID injury.
- Bovine colostrum supplementation during endurance running training improves recovery, but not performance.
PMID 12188088 · 2002 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- Oral bovine colostrum supplementation enhances buffer capacity but not rowing performance in elite female rowers.
PMID 12432178 · 2002 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males.
PMID 12923655 · 2003 · randomized controlled trialSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
- Protein metabolism and strength performance after bovine colostrum supplementation.
PMID 15789141 · 2005 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- The effect of bovine colostrum supplementation on salivary IgA in distance runners.
PMID 16676703 · 2006 · randomized controlled trialIndividual runner/swimmer RCTs reported changes, but pooled analysis did not find a significant salivary-IgA effect. This surrogate does not establish causally fewer infections.
- Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers.
PMID 20601740 · 2010 · randomized controlled trialIndividual runner/swimmer RCTs reported changes, but pooled analysis did not find a significant salivary-IgA effect. This surrogate does not establish causally fewer infections.
- Bovine colostrum supplementation during running training increases intestinal permeability.
PMID 22253980 · 2009 · randomized controlled trialIn n=30 adult male runners receiving 60 g/day for eight weeks, L/R rose 251 +/- 140% with colostrum versus 21 +/- 35% with whey (p<.05) and -7 +/- 13% in controls (p<.02). This potentially adverse chronic result must be shown alongside acute protection; increased macromolecular transport is one hypothesis.
- Effects of bovine colostrum supplementation on upper respiratory illness in active males.
PMID 24200515 · 2014 · randomized controlled trialSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
- Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers.
PMID 27357095 · 2016 · randomized controlled trialAn n=8 crossover RCT found an approximately threefold exercise-related lactulose:rhamnose rise (0.32 to 1.0; p<.01). Colostrum or zinc-carnosine attenuated the rise by about 70% after 14 days; the combination showed about 30% attenuation after two days. Related heat/exercise marker trials support a narrow acute context.
- A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players.
PMID 28285432 · 2018 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- Intestinal fatty acid-binding protein and gut permeability responses to exercise.
PMID 28290057 · 2017 · randomized controlled trialAn n=8 crossover RCT found an approximately threefold exercise-related lactulose:rhamnose rise (0.32 to 1.0; p<.01). Colostrum or zinc-carnosine attenuated the rise by about 70% after 14 days; the combination showed about 30% attenuation after two days. Related heat/exercise marker trials support a narrow acute context.
- The effect of bovine colostrum supplementation on intestinal injury and circulating intestinal bacterial DNA following exercise in the heat.
PMID 29574607 · 2019 · catalogued study; design described in outcome contextAn n=8 crossover RCT found an approximately threefold exercise-related lactulose:rhamnose rise (0.32 to 1.0; p<.01). Colostrum or zinc-carnosine attenuated the rise by about 70% after 14 days; the combination showed about 30% attenuation after two days. Related heat/exercise marker trials support a narrow acute context.
- Bovine colostrum and product intervention associated with relief of childhood infectious diarrhea.
PMID 30816291 · 2019 · meta-analysisA five-RCT meta-analysis in sick children found 1.42 fewer stools/day (95% CI -2.70 to -0.14), diarrhea occurrence OR 0.29 (95% CI 0.16–0.52), and pathogen detection OR 0.29 (95% CI 0.08–0.71). OR 0.29 means lower odds, not an established 71% absolute or relative risk reduction; findings do not establish healthy-adult prophylaxis.
- Immunological Outcomes of Bovine Colostrum Supplementation in Trained and Physically Active People: A Systematic Review and Meta-Analysis.
PMID 32276466 · 2020 · meta-analysisSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.; Individual runner/swimmer RCTs reported changes, but pooled analysis did not find a significant salivary-IgA effect. This surrogate does not establish causally fewer infections.
- The Use of Bovine Colostrum in Sport and Exercise.
PMID 34073917 · 2021 · reviewSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
- Moderate Dose Bovine Colostrum Supplementation in Prevention of Upper Respiratory Tract Infections in Medical University Students: A Randomized, Triple Blind, Placebo-Controlled Trial.
PMID 37111143 · 2023 · randomized controlled trialSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
- Six Weeks of Supplementation with Bovine Colostrum Effectively Reduces URTIs Symptoms Frequency and Gravity for Up to 20 Weeks in Pre-School Children.
PMID 37630816 · 2023 · randomized controlled trialSome small RCTs in active men, students and preschool children reported fewer respiratory symptom episodes/days over 4–12 weeks. However a 10-RCT meta-analysis (n=239) found little or no effect on serum immunoglobulins, immune-cell measures or salivary IgA; mechanisms and the optimal protocol remain uncertain and some trials were sponsored.
- Long-Term Bovine Colostrum Supplementation in Football Players.
PMID 38004173 · 2023 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- Therapeutics effects of bovine colostrum applications on gastrointestinal diseases: a systematic review.
PMID 38409162 · 2024 · systematic reviewA five-RCT meta-analysis in sick children found 1.42 fewer stools/day (95% CI -2.70 to -0.14), diarrhea occurrence OR 0.29 (95% CI 0.16–0.52), and pathogen detection OR 0.29 (95% CI 0.08–0.71). OR 0.29 means lower odds, not an established 71% absolute or relative risk reduction; findings do not establish healthy-adult prophylaxis.
- The effect of 12-week high-dose Colostrum Bovinum supplementation on immunological, hematological and biochemical markers in endurance athletes: a randomized crossover placebo-controlled study.
PMID 39497827 · 2024 · randomized controlled trialEndurance-running recovery improved without performance gains; elite female rowers had greater buffering without better rowing. Soccer studies suggest maintained performance/lower inflammatory markers, but the wider RCT set is inconsistent and does not show a reliable ergogenic effect.
- The Effects of Colostrum Bovinum Supplementation on Human Body Fat Content and/or Blood Lipid Profile: A Systematic Review of Clinical Trials.
PMID 42197039 · 2026 · systematic reviewA 2026 systematic review is indexed, but the source explicitly leaves direction unresolved. No weight-loss or lipid-treatment claim can be inferred from that citation.
Community comments
No approved comments yet. Comments are held for moderation.